Mergon Group Acquired Inmo Tech Limited
The international manufacturer has purchased the Enniscrone-based company to bolster its medical component production.
Updated on Oct. 6, 2026 in Healthcare
Live Poll
Do you believe local manufacturing benefits when smaller firms are acquired by larger global companies?
Mergon Group has completed the acquisition of Inmo Tech Limited, a firm specializing in precision injection-moulded components. The deal integrates Inmo Tech manufacturing facilities and personnel into the broader Mergon network.
Why it matters
This acquisition allows Mergon Group to expand its healthcare manufacturing capabilities by leveraging the specialist injection moulding expertise of Inmo Tech. The merger is intended to enhance service offerings for existing global clients.
Mergon Group currently operates international manufacturing sites in Ireland, the United States, the Czech Republic, the UK, and Mexico. The company serves major industry clients including Abbott, Beckman Coulter, and Pfizer.
The players
Mergon Group
An international manufacturing firm headquartered in Castlepollard that provides precision components to healthcare and industrial sectors.
Inmo Tech Limited
A precision injection-moulding specialist based in Enniscrone that supplies components for the healthcare industry.
Abbott
A major global healthcare and medical devices company that relies on precision components supplied by manufacturers like Mergon.
Beckman Coulter
A clinical diagnostics company that utilizes specialized components for its medical testing systems.
Pfizer
A leading global pharmaceutical corporation that sources precision-moulded parts for its healthcare operations.
The details
The integration incorporates Inmo Tech's existing Enniscrone facility and staff into the Mergon Group corporate structure. Both parties plan to utilize the combined strengths of the organizations to provide improved support for their customer base.
Timeline
Mergon Group announced the acquisition of Inmo Tech on October 6, 2026.
Market Landscape
This acquisition aligns with the broader industry trend of consolidation within the precision healthcare manufacturing sector. It positions Mergon Group to more effectively compete against rival component suppliers by expanding its specialized manufacturing footprint.
For clients of Mergon Group and Inmo Tech, the acquisition aims to provide more robust manufacturing capacity and improved long-term support for medical product development. Customers should expect deeper integration of services as the two manufacturing teams combine operations.
The takeaway
The union of these two entities suggests a shift toward more centralized production capabilities for critical medical supplies. Industry observers should monitor how this integration influences production timelines for the major healthcare firms that rely on these components.
Further reading
Learn more about the latest developments in the Healthcare sector.
Source note: This article includes information reported by Westmeath Examiner.
Live Poll
Do you believe local manufacturing benefits when smaller firms are acquired by larger global companies?
